Deutsche Bank Ag\ Neuro Bo Pharmaceuticals, Inc. Transaction History

Deutsche Bank Ag\

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 04, 2021	SELL	$2.73 - $4.52 $84,875 - $140,526	-31,090 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$2.74 - $4.63 $77,555 - $131,052	28,305 Added 1016.34%	31,090 $104,000
Q1 2021 May 13, 2021	SELL	$3.93 - $6.68 $1,084 - $1,843	-276 Reduced 9.02%	2,785 $12,000
Q4 2020 Feb 16, 2021	BUY	$5.02 - $6.59 $4,412 - $5,792	879 Added 40.28%	3,061 $16,000
Q3 2020 Nov 12, 2020	BUY	$5.41 - $8.67 $1,146 - $1,838	212 Added 10.76%	2,182 $12,000
Q2 2020 Aug 13, 2020	BUY	$8.05 - $29.44 $15,858 - $57,996	1,970 New	1,970 $16,000

Ticker NRBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 888,693
Market Cap $2.4M
Description
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative, infectious, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which is in Phase 2/3 clinical trials to treat patients with moderate coronavirus disease (COVID-19); NB-01 for the tr...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.